TY - JOUR
AB - Posters 61 studies are needed to establish the optimum dosing regimen P74 for longer-term use of this medication. Comparative evaluation of the efficacy and safety of dermabrasion followed by a prostaglandin E2 analogue (dinoprostone) versus dermabrasion followed by P73 tacrolimus ointment 0
1% in localized stable vitiligo A novel approach to systemic monitoring in a pandemic J. Kaur, S. Kumar and B. Brar R. Lapsley and S. Weatherhead Guru Gobind Singh Medical College and Hospital, Faridkot, India Royal Victoria Infirmary, Newcastle upon Tyne, UK Dinoprostone, a prostaglandin (PG) E2 analogue has been One of the many logistical challenges facing our dermatology found to cause repigmentation in vitiliginous lesions (Prota G, department during the COVID-19 pandemic was how to con- Vincensi MR, Napolitano A. Latanoprost stimulates eumelano- tinue safely the systemic monitoring of dermatology patients genesis in iridial melanocytes of cynomolgus monkeys. Pigment on immunosuppressive medication and retinoids. The majority Cell Res 2000; 13:147–50). There is expression of various PG of these patients in our tertiary referral centre are entirely receptors over the melanocytes (Parsad D, Pandhi R, Dogra S, monitored by the hospital, with general practitioners having Kumar B. Topical prostaglandin analogue (PGE2) in vitiligo – a little/no capacity to 
TI - P73: A novel approach to systemic monitoring in a pandemic
JO - British Journal of Dermatology
DO - 10.1111/bjd.20038
DA - 2021-07-01
UR - https://www.deepdyve.com/lp/oxford-university-press/p73-a-novel-approach-to-systemic-monitoring-in-a-pandemic-01ATYR20Cu
SP - 61
EP - 61
VL - 185
IS - S1
DP - DeepDyve
ER -